Finely tuned glutamate receptor inhibitors as novel therapeutics for neurodegenerative disorders

Project: Research

Status	Finished
Effective start/end date	1/01/21 → 31/12/24

Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology
Muraleetharan, A., Wang, Y., Rowe, M. C., Gould, A., Gregory, K. J. & Hellyer, S. D., Jun 2023, In: Molecular Pharmacology. 103, 6, p. 325-338 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

2 Citations (Scopus)
Adenosine receptor signalling in Alzheimer’s disease
Trinh, P. N. H., Baltos, J. A., Hellyer, S. D., May, L. T. & Gregory, K. J., Jul 2022, In: Purinergic Signalling. 18, p. 359–381 23 p.
Research output: Contribution to journal › Review Article › Research › peer-review

Open Access

21 Citations (Scopus)
Chemical biology-based approaches to study adenosine A_2A − dopamine D₂ receptor heteromers
Gregory, K. J. & Jörg, M., 29 Mar 2022, In: Purinergic Signalling. 18, 4, p. 395–398 4 p.
Research output: Contribution to journal › Article › Other › peer-review

1 Citation (Scopus)

Project Details